Table 5 Comparison of overall survival and cancer-specific survival between high ATPD and low ATPD groups by using various cutoff values of ATPD.
From: Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
Cutoff value (HU) | Two-year OS rate | P value (log rank test) | Two-year CSS rate | P value (log rank test) | ||
|---|---|---|---|---|---|---|
High ATPD | Low ATPD | High ATPD | Low ATPD | |||
35 | 77.0% (n = 199) | 51.7% (n = 31) | < 0.01 | 79.9% (m = 199) | 56.7% (n = 31) | < 0.01 |
40 | 76.8% (n = 163) | 65.1% (n = 67) | 0.19 | 80.3% (n = 163) | 67.7% (n = 67) | 0.05 |
44 (present study) | 80.2% (n = 110) | 66.4% (n = 120) | 0.04 | 83.2% (n = 110) | 70.1% (n = 120) | 0.01 |
50 | 84.6% (n = 26) | 71.7% (n = 204) | 0.14 | 84.6% (n = 26) | 75.4% (n = 204) | 0.33 |
